Botox Intervention Improves Facial Asymmetry After Nerve Damage
By Elana Gotkine HealthDay Reporter
TUESDAY, March 18, 2025 -- For patients with severe oral commissure droop from facial nerve damage undergoing surgery, botulinum toxin type A (BoNT-A) treatment helps to alleviate muscle hyperactivity, leading to improvement in facial asymmetry, according to a study published in the March issue of Plastic and Reconstructive Surgery.
Hao Ma, M.D., from Shanghai Ninth People's Hospital, and colleagues examined the impact of BoNT-A treatment on the unaffected side in 38 patients with severe oral commissure droop from facial nerve damage with respect to facial symmetry and brain connectivity. Participants were divided into two groups: those who did and did not receive BoNT-A injections on the unaffected side (20 and 18 patients, respectively).
The researchers found that BoNT-A treatment improved facial symmetry and induced significant modifications in brain functional network connectivity. The modifications extended beyond the sensorimotor network, involving high-level cognitive processes. There was a significant correlation between functional network connectivity and the degree of asymmetry.
"BoNT-A treatment appears to promote significant modifications in functional brain network connectivity, thereby sustaining the positive effects of BoNT-A," the authors write. "Our findings imply that the facial asymmetry is linked to the characteristics of large-scale functional networks."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-19 06:00
Read more

- Sexual Assault Triples Suicide Risk Among Veterans
- Survey Reveals Women May Be Experiencing Perimenopause in Their 40s
- FDA Commissioner: No Major Reorganization, Just Smart Reforms
- Medically Tailored Meals Are Saving Costs in 49 States
- Anemia In Pregnancy Increases Risk Of Heart Defects
- Stress Quadruples Risk Of COPD Flares, Study Says
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions